The effect of definity on systemic and pulmonary hemodynamics in patients

Kevin Wei, Michael L. Main, Roberto M. Lang, Allan Klein, Stephen Angeli, Carmelo Panetta, Issam Mikati, L. Veronica Lee, Jonathan A. Bernstein, Masood Ahmad

    Research output: Contribution to journalArticle

    24 Citations (Scopus)

    Abstract

    Background: The purpose of this study was to evaluate the pulmonary and systemic hemodynamic effects of Definity in patients with normal as well as those with elevated pulmonary artery pressure at baseline. Secondary objectives of the study were to evaluate safety and determine whether any potential immunologic reactions develop after Definity administration. Methods: Patients with normal and elevated pulmonary artery systolic pressure undergoing right-heart catheterization received Definity (10 μL/kg) as a slow bolus over 30 to 60 sec. Multiple sequential measurements of right atrial pressure, pulmonary artery systolic pressure, pulmonary artery diastolic pressure, mean pulmonary artery pressure, cardiac output, and pulmonary capillary wedge pressure were made before and after Definity administration. Vital signs, electrocardiograms, and blood samples were taken at multiple time points. Patients were followed for the development of adverse events. Results: A total of 32 patients (16 with elevated pulmonary artery systolic pressure > 35 mm Hg) were enrolled. No significant changes in any pulmonary or systemic hemodynamic parameters, vital sign values, electrocardiographic data, or laboratory variables were found for data obtained before versus after receipt of Definity. Conclusions: The administration of Definity at the approved dosage does not change pulmonary or systemic hemodynamics in control patients or those with mild to moderate pulmonary hypertension. No significant changes were noted in a wide array of clinical and laboratory safety assessments after patients were exposed to Definity.

    Original languageEnglish (US)
    Pages (from-to)584-588
    Number of pages5
    JournalJournal of the American Society of Echocardiography
    Volume25
    Issue number5
    DOIs
    StatePublished - May 2012

    Fingerprint

    Pulmonary Artery
    Hemodynamics
    Lung
    Blood Pressure
    Vital Signs
    Safety
    Pressure
    Pulmonary Wedge Pressure
    Atrial Pressure
    Cardiac Catheterization
    Definity
    Pulmonary Hypertension
    Cardiac Output
    Electrocardiography

    Keywords

    • Contrast echocardiography
    • Hemodynamics
    • Pulmonary artery pressure
    • Safety

    ASJC Scopus subject areas

    • Radiology Nuclear Medicine and imaging
    • Cardiology and Cardiovascular Medicine

    Cite this

    The effect of definity on systemic and pulmonary hemodynamics in patients. / Wei, Kevin; Main, Michael L.; Lang, Roberto M.; Klein, Allan; Angeli, Stephen; Panetta, Carmelo; Mikati, Issam; Lee, L. Veronica; Bernstein, Jonathan A.; Ahmad, Masood.

    In: Journal of the American Society of Echocardiography, Vol. 25, No. 5, 05.2012, p. 584-588.

    Research output: Contribution to journalArticle

    Wei, K, Main, ML, Lang, RM, Klein, A, Angeli, S, Panetta, C, Mikati, I, Lee, LV, Bernstein, JA & Ahmad, M 2012, 'The effect of definity on systemic and pulmonary hemodynamics in patients', Journal of the American Society of Echocardiography, vol. 25, no. 5, pp. 584-588. https://doi.org/10.1016/j.echo.2012.01.019
    Wei, Kevin ; Main, Michael L. ; Lang, Roberto M. ; Klein, Allan ; Angeli, Stephen ; Panetta, Carmelo ; Mikati, Issam ; Lee, L. Veronica ; Bernstein, Jonathan A. ; Ahmad, Masood. / The effect of definity on systemic and pulmonary hemodynamics in patients. In: Journal of the American Society of Echocardiography. 2012 ; Vol. 25, No. 5. pp. 584-588.
    @article{94bd46a1a4ad4b9583948987c3cb15c1,
    title = "The effect of definity on systemic and pulmonary hemodynamics in patients",
    abstract = "Background: The purpose of this study was to evaluate the pulmonary and systemic hemodynamic effects of Definity in patients with normal as well as those with elevated pulmonary artery pressure at baseline. Secondary objectives of the study were to evaluate safety and determine whether any potential immunologic reactions develop after Definity administration. Methods: Patients with normal and elevated pulmonary artery systolic pressure undergoing right-heart catheterization received Definity (10 μL/kg) as a slow bolus over 30 to 60 sec. Multiple sequential measurements of right atrial pressure, pulmonary artery systolic pressure, pulmonary artery diastolic pressure, mean pulmonary artery pressure, cardiac output, and pulmonary capillary wedge pressure were made before and after Definity administration. Vital signs, electrocardiograms, and blood samples were taken at multiple time points. Patients were followed for the development of adverse events. Results: A total of 32 patients (16 with elevated pulmonary artery systolic pressure > 35 mm Hg) were enrolled. No significant changes in any pulmonary or systemic hemodynamic parameters, vital sign values, electrocardiographic data, or laboratory variables were found for data obtained before versus after receipt of Definity. Conclusions: The administration of Definity at the approved dosage does not change pulmonary or systemic hemodynamics in control patients or those with mild to moderate pulmonary hypertension. No significant changes were noted in a wide array of clinical and laboratory safety assessments after patients were exposed to Definity.",
    keywords = "Contrast echocardiography, Hemodynamics, Pulmonary artery pressure, Safety",
    author = "Kevin Wei and Main, {Michael L.} and Lang, {Roberto M.} and Allan Klein and Stephen Angeli and Carmelo Panetta and Issam Mikati and Lee, {L. Veronica} and Bernstein, {Jonathan A.} and Masood Ahmad",
    year = "2012",
    month = "5",
    doi = "10.1016/j.echo.2012.01.019",
    language = "English (US)",
    volume = "25",
    pages = "584--588",
    journal = "Journal of the American Society of Echocardiography",
    issn = "0894-7317",
    publisher = "Mosby Inc.",
    number = "5",

    }

    TY - JOUR

    T1 - The effect of definity on systemic and pulmonary hemodynamics in patients

    AU - Wei, Kevin

    AU - Main, Michael L.

    AU - Lang, Roberto M.

    AU - Klein, Allan

    AU - Angeli, Stephen

    AU - Panetta, Carmelo

    AU - Mikati, Issam

    AU - Lee, L. Veronica

    AU - Bernstein, Jonathan A.

    AU - Ahmad, Masood

    PY - 2012/5

    Y1 - 2012/5

    N2 - Background: The purpose of this study was to evaluate the pulmonary and systemic hemodynamic effects of Definity in patients with normal as well as those with elevated pulmonary artery pressure at baseline. Secondary objectives of the study were to evaluate safety and determine whether any potential immunologic reactions develop after Definity administration. Methods: Patients with normal and elevated pulmonary artery systolic pressure undergoing right-heart catheterization received Definity (10 μL/kg) as a slow bolus over 30 to 60 sec. Multiple sequential measurements of right atrial pressure, pulmonary artery systolic pressure, pulmonary artery diastolic pressure, mean pulmonary artery pressure, cardiac output, and pulmonary capillary wedge pressure were made before and after Definity administration. Vital signs, electrocardiograms, and blood samples were taken at multiple time points. Patients were followed for the development of adverse events. Results: A total of 32 patients (16 with elevated pulmonary artery systolic pressure > 35 mm Hg) were enrolled. No significant changes in any pulmonary or systemic hemodynamic parameters, vital sign values, electrocardiographic data, or laboratory variables were found for data obtained before versus after receipt of Definity. Conclusions: The administration of Definity at the approved dosage does not change pulmonary or systemic hemodynamics in control patients or those with mild to moderate pulmonary hypertension. No significant changes were noted in a wide array of clinical and laboratory safety assessments after patients were exposed to Definity.

    AB - Background: The purpose of this study was to evaluate the pulmonary and systemic hemodynamic effects of Definity in patients with normal as well as those with elevated pulmonary artery pressure at baseline. Secondary objectives of the study were to evaluate safety and determine whether any potential immunologic reactions develop after Definity administration. Methods: Patients with normal and elevated pulmonary artery systolic pressure undergoing right-heart catheterization received Definity (10 μL/kg) as a slow bolus over 30 to 60 sec. Multiple sequential measurements of right atrial pressure, pulmonary artery systolic pressure, pulmonary artery diastolic pressure, mean pulmonary artery pressure, cardiac output, and pulmonary capillary wedge pressure were made before and after Definity administration. Vital signs, electrocardiograms, and blood samples were taken at multiple time points. Patients were followed for the development of adverse events. Results: A total of 32 patients (16 with elevated pulmonary artery systolic pressure > 35 mm Hg) were enrolled. No significant changes in any pulmonary or systemic hemodynamic parameters, vital sign values, electrocardiographic data, or laboratory variables were found for data obtained before versus after receipt of Definity. Conclusions: The administration of Definity at the approved dosage does not change pulmonary or systemic hemodynamics in control patients or those with mild to moderate pulmonary hypertension. No significant changes were noted in a wide array of clinical and laboratory safety assessments after patients were exposed to Definity.

    KW - Contrast echocardiography

    KW - Hemodynamics

    KW - Pulmonary artery pressure

    KW - Safety

    UR - http://www.scopus.com/inward/record.url?scp=84860237550&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84860237550&partnerID=8YFLogxK

    U2 - 10.1016/j.echo.2012.01.019

    DO - 10.1016/j.echo.2012.01.019

    M3 - Article

    C2 - 22365709

    AN - SCOPUS:84860237550

    VL - 25

    SP - 584

    EP - 588

    JO - Journal of the American Society of Echocardiography

    JF - Journal of the American Society of Echocardiography

    SN - 0894-7317

    IS - 5

    ER -